Chemoinformaics analysis of 7-O-ACETYL-8-EPI-LOGANIC-ACID
| Molecular Weight | 142.198 | nRot | 6 |
| Heavy Atom Molecular Weight | 128.086 | nRig | 2 |
| Exact Molecular Weight | 142.099 | nRing | 0 |
| Solubility: LogS | -2.044 | nHRing | 0 |
| Solubility: LogP | 2.331 | No. of Aliphatic Rings | 0 |
| Acid Count | 1 | No. of Aromatic Rings | 0 |
| Base Count | 0 | No. of Aliphatic Carbocycles Rings | 0 |
| Atoms Count | 24 | No. of Aliphatic Hetero Cycles | 0 |
| No. of Heavy Atom | 10 | No. of Aromatic Carbocycles | 0 |
| nHetero | 2 | No. of Aromatic Hetero Cycles | 0 |
| nBridge Head | 0 | No. Saturated Carbocycles | 0 |
| No. of Hydrogen atom | 14 | No. of Saturated Hetero Cycles | 0 |
| No. of Carbon atom | 8 | No. of Saturated Rings | 0 |
| No. of Nitrogen atom | 0 | No. of Arom Atom | 0 |
| No. of Oxygen atom | 2 | No. of Arom Bond | 0 |
| nHA | 1 | APOL | 24.2991 |
| nHD | 1 | BPOL | 14.9129 |
| QED | 0.456 |
| Synth | 1.948 |
| Natural Product Likeliness | 1.335 |
| NR-PPAR-gamma | 0.85 |
| Lipinski | Accepted |
| Pfizer | Accepted |
| GSK | Accepted |
| Golden Triangle | Rejected |
| Pgp-inh | 0.001 |
| Pgp-sub | 0 |
| HIA | 0.007 |
| CACO-2 | -5.028 |
| MDCK | 0.000022 |
| BBB | 0.526 |
| PPB | 0.845833 |
| VDSS | 0.234 |
| FU | 0.094765 |
| CYP1A2-inh | 0.035 |
| CYP1A2-sub | 0.277 |
| CYP2c19-inh | 0.021 |
| CYP2c19-sub | 0.179 |
| CYP2c9-inh | 0.016 |
| CYP2c9-sub | 0.958 |
| CYP2d6-inh | 0.006 |
| CYP2d6-sub | 0.369 |
| CYP3a4-inh | 0.014 |
| CYP3a4-sub | 0.05 |
| CL | 4.255 |
| T12 | 0.822 |
| hERG | 0.009 |
| Ames | 0.01 |
| ROA | 0.52 |
| SkinSen | 0.595 |
| Carcinogencity | 0.141 |
| EI | 0.991 |
| Respiratory | 0.508 |
| NR-Aromatase | 0.008 |
| Antiviral | No |
| Prediction | 0.954314 |